184 related articles for article (PubMed ID: 30908588)
1. What is the meaning of PASAT rejection in multiple sclerosis?
Cortés-Martínez A; Matias-Guiu JA; Pytel V; Montero P; Moreno-Ramos T; Matías-Guiu J
Acta Neurol Scand; 2019 Jun; 139(6):559-562. PubMed ID: 30908588
[TBL] [Abstract][Full Text] [Related]
2. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a brief electronic screening test for cognitive impairment in multiple sclerosis (SCI-MS Test).
Meca-Lallana JE; Prieto-González JM; Jimenez-Veiga J; Carreón-Guarnizo E; Jiménez-Martín I; Hernández-Clares R; Sistiaga-Berrondo A; Carles-Dies R; García-Molina E; Cerdán-Sánchez M; Costa-Arpín E; Croitoru I; Castillo-Triviño T; Iniesta-Martinez F; García-Pérez E; Olascoaga-Urtaza J
Mult Scler Relat Disord; 2019 Feb; 28():50-56. PubMed ID: 30553169
[TBL] [Abstract][Full Text] [Related]
4. The relationship between cognitive function and body mass index in multiple sclerosis patients.
Owji M; Ashraf-Ganjouei A; Sahraian MA; Bidadian M; Ghadiri F; Naser Moghadasi A
Mult Scler Relat Disord; 2019 Jul; 32():37-40. PubMed ID: 31030017
[TBL] [Abstract][Full Text] [Related]
5. Cognitive screening in Multiple Sclerosis: the Five-Point Test as a substitute for the PASAT in measuring executive function.
Hansen S; Muenssinger J; Kronhofmann S; Lautenbacher S; Oschmann P; Keune PM
Clin Neuropsychol; 2017 Jan; 31(1):179-192. PubMed ID: 27707354
[TBL] [Abstract][Full Text] [Related]
6. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
López-Góngora M; Querol L; Escartín A
BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
[TBL] [Abstract][Full Text] [Related]
7. Including a subject-paced trial may make the PASAT more acceptable for MS patients.
Bosnes O; Dahl OP; Almkvist O
Acta Neurol Scand; 2015 Oct; 132(4):219-25. PubMed ID: 25690091
[TBL] [Abstract][Full Text] [Related]
8. Information-processing speed is the primary deficit underlying the poor performance of multiple sclerosis patients in the Paced Auditory Serial Addition Test (PASAT).
Forn C; Belenguer A; Parcet-Ibars MA; Avila C
J Clin Exp Neuropsychol; 2008 Oct; 30(7):789-96. PubMed ID: 18608672
[TBL] [Abstract][Full Text] [Related]
9. Trail Making Test Could Predict Impairment in Cognitive Domains in Patients with Multiple Sclerosis: A Study of Diagnostic Accuracy.
Kabiri S; Jameie M; Balali P; Adib Moradi S; Sanjari Moghaddam H; Aghamollaii V; Harirchian MH
Arch Clin Neuropsychol; 2023 Jan; 38(1):37-48. PubMed ID: 35901460
[TBL] [Abstract][Full Text] [Related]
10. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
[TBL] [Abstract][Full Text] [Related]
11. Structural MRI correlates of PASAT performance in multiple sclerosis.
Matias-Guiu JA; Cortés-Martínez A; Montero P; Pytel V; Moreno-Ramos T; Jorquera M; Yus M; Arrazola J; Matías-Guiu J
BMC Neurol; 2018 Dec; 18(1):214. PubMed ID: 30572821
[TBL] [Abstract][Full Text] [Related]
12. Cognitive fatigability in multiple sclerosis: How does performance decline over time on the Paced Auditory Serial Addition Test?
Agyemang C; Berard JA; Walker LAS
Mult Scler Relat Disord; 2021 Sep; 54():103130. PubMed ID: 34273611
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Guy's Neurological Disability Scale as a screening tool for cognitive impairment in multiple sclerosis.
Akatani R; Chihara N; Tachibana H; Koto S; Kowa H; Kanda F; Matsumoto R; Toda T
Mult Scler Relat Disord; 2019 Oct; 35():272-275. PubMed ID: 31442905
[TBL] [Abstract][Full Text] [Related]
14. Paced visual serial addition test in multiple sclerosis.
Nagels G; Geentjens L; Kos D; Vleugels L; D'hooghe MB; Van Asch P; Vuylsteke K; De Deyn PP
Clin Neurol Neurosurg; 2005 Apr; 107(3):218-22. PubMed ID: 15823678
[TBL] [Abstract][Full Text] [Related]
15. Cognitive Impairment in Multiple Sclerosis: A Review of Neuropsychological Assessments.
Korakas N; Tsolaki M
Cogn Behav Neurol; 2016 Jun; 29(2):55-67. PubMed ID: 27336803
[TBL] [Abstract][Full Text] [Related]
16. Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis.
Lazeron RH; Boringa JB; Schouten M; Uitdehaag BM; Bergers E; Lindeboom J; Eikelenboom MI; Scheltens PH; Barkhof F; Polman CH
Mult Scler; 2005 Oct; 11(5):524-31. PubMed ID: 16193889
[TBL] [Abstract][Full Text] [Related]
17. Utilization of the auditory consonant trigram test to screen for cognitive impairment in patients with multiple sclerosis: comparison with the paced auditory serial addition test.
Ozakbas S; Ormeci B; Akdede BB; Alptekin K; Idiman E
Mult Scler; 2004 Dec; 10(6):686-9. PubMed ID: 15584495
[TBL] [Abstract][Full Text] [Related]
18. Detecting cognitive fatigue in multiple sclerosis: method matters.
Walker LA; Berard JA; Berrigan LI; Rees LM; Freedman MS
J Neurol Sci; 2012 May; 316(1-2):86-92. PubMed ID: 22336698
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients.
Niccolai C; Portaccio E; Goretti B; Hakiki B; Giannini M; Pastò L; Righini I; Falautano M; Minacapelli E; Martinelli V; Incerti C; Nocentini U; Fenu G; Cocco E; Marrosu MG; Garofalo E; Ambra FI; Maddestra M; Consalvo M; Viterbo RG; Trojano M; Losignore NA; Zimatore GB; Pietrolongo E; Lugaresi A; Pippolo L; Roscio M; Ghezzi A; Castellano D; Stecchi S; Amato MP
BMC Neurol; 2015 Oct; 15():204. PubMed ID: 26472052
[TBL] [Abstract][Full Text] [Related]
20. Education protects against cognitive changes associated with multiple sclerosis.
Scarpazza C; Braghittoni D; Casale B; Malagú S; Mattioli F; di Pellegrino G; Ladavas E
Restor Neurol Neurosci; 2013; 31(5):619-31. PubMed ID: 23735315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
